Among single stocks, argenx SE ARGX.BRjumped 5.6% after the Dutch biopharmaceutical company announced a deal to acquire a U.S. FDA Priority Review Voucher (PRV) for $102 million. Adds comments, details Nov 30 (Reuters) - European shares rose on Wednesday, heading for their second straight month of gains, on cooler-than-expected euro zone inflation and hopes for easing COVID curbs in China. He said investor sentiment was getting a boost from accelerating vaccination plans by the Chinese government and a softening stance from health officials regarding the country's zero-COVID policies.